Zachary Zubulake

FDA granted priority review for Pfizer’s Marstacimab, a weekly subcutaneous anti-TFPI to treat pediatric and inhibitor hemophilia.

Marcio Temtem, vice president, Strategic Business Management, Hovione, addresses molecule complexity, speed, and regionalization via integrated manufacturing.

ACG’s Shirwal site is the first pharmaceutical packaging site in the WEF Lighthouse Network, using digital tools to cut defects and boost sustainability.

FDA has granted priority review to AstraZeneca's Datroway for the first-line treatment of metastatic TNBC treatment.

EMA recommends Kygevvi for rare thymidine kinase 2 deficiency. It is the first authorized treatment for this disease.

EMA recommends Rezurock (belumosudil) for chronic graft-versus-host disease, with the drug. Meetings unmet needs via conditional authorization.

This week's coverage discusses the M&A report, $50B+ investments, automated cell therapy, vaccine approvals, and risks from the US leaving the WHO.

M&A report claims that pharma is now targeting vertical integration and manufacturing control in radiopharma, GLP-1s, and ADCs to secure the supply chain.

Vetter's €1.5 billion expansion adds German commercial and Illinois clinical sites to support global sterile injectable drug supply.

The ROSS CDA-200 optimizes viscous pharmaceutical batches via independent agitation, vacuum, and thermal control.

Halo Pharma becomes a standalone drug product CDMO after the sale of Noramco’s API assets, adding sterile services by H2 2026.

WuXi Biologics and HanchorBio partner to accelerate multi-functional fusion protein translation via end-to-end CMC and GMP services.

Laine Mello, director of Marketin, Ecolab, details how AI, continuous manufacturing, and Pharma 4.0 drive bioprocessing efficiency and cost savings.

Raj Puri, CCO, Argonaut Manufactoring, provides key insight on navigating tariffs, supply redundancy, and the risks of compressed timelines.

Mirum Pharmaceuticals acquires Bluejay Therapeutics, adding a Phase 3 antibody for chronic hepatitis delta virus to its pipeline.

In a 2026 industry outlook interview, Laine Mello, Ecolab Life Sciences, explains how next-gen therapies, digitalization, and partnerships drive pharma agility.

This week's coverage discusses pharma advances in sustainable packaging and digital standards amid trade risks from Greenland tariffs and falling workforce morale

The United States Pharmacopeia is developing digital standards for digital-first workflows and regulatory confidence.

ACG’s new SuperPod reduces blister size and boosts efficiency and sustainability for moisture-sensitive drug products.

The three firms offer a pre-verified platform for large-volume subcutaneous delivery of biologics to enable home self-administration.

West has launched Synchrony S1, a prefillable syringe system to simplify biologic delivery and combination product needs.

Syngene has extended its Bristol Myers Squibb alliance to 2035 and invests in automation to accelerate integrated drug development and manufacturing.

Sharp increases European injectable assembly and secondary packaging capacity to support the rising demand for pre-filled syringes and autoinjectors.

The week’s coverage discusses leveraging agentic AI, sustainability, and resilient supply chains to transform global drug development and safety.